A hidden cause of hypokalemic paralysis in a patient with prostate cancer

Supportive Care in Cancer

Volumn 12, Issue 11, 2004, Pages 810-812

  Cheng, Chih Jen ^a   Chen, Yeong Hwang ^a   Chau, Tom ^a   Lin, Shih Hua ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Hypokalemia; Licorice; Paralysis; Prostate cancer

Indexed keywords

ALDOSTERONE; CARBONIC ACID; GLYCYRRHIZIC ACID; HERBACEOUS AGENT; HORMONE; HYDROCORTISONE; POTASSIUM CHLORIDE; POTASSIUM ION; RENIN;

AGED; ALTERNATIVE MEDICINE; ANAMNESIS; BIOCHEMISTRY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONVALESCENCE; DOSE RESPONSE; DRUG WITHDRAWAL; GLYCYRRHIZA; HERBAL MEDICINE; HORMONAL THERAPY; HUMAN; HYPERTENSION; HYPOKALEMIA; KIDNEY FUNCTION; KOREA; LIMB DISEASE; MALE; METABOLIC ALKALOSIS; MYALGIA; ORCHIECTOMY; PARALYSIS; PATHOGENESIS; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROSTATE CARCINOMA; PSEUDOHYPOALDOSTERONISM; REVIEW; SUPPLEMENTATION;

AGED; FOLLOW-UP STUDIES; GLYCYRRHIZA; HUMANS; HYPOKALEMIC PERIODIC PARALYSIS; MALE; PHYTOTHERAPY; POTASSIUM CHLORIDE; PROSTATIC NEOPLASMS; RISK ASSESSMENT; SELF MEDICATION; TAIWAN;

EID: 11244262689     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-004-0656-8     Document Type: Review

References (17)

1. Arase Y, Ikeda K, Murashima N, et al (1997) The long term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer 79:1494-1500
2. Blachley JD, Knochel JP (1980) Tobacoo chewer's hypokalemia: licorice revisited. N Engl J Med 302:784-785
3. Cinatl J, Morgenstern B, Batter G, et al (2003) Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 361:2045-2046
4. DiPaola RS, Zhang H, Lambert GH, et al (1998) Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. New Engl J Med 339:785-791
5. Eng J, Ramsum D, Verhoef M, et al (2003) A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer. Integr Cancer Ther 2(3):212-216
6. Harris P, Finlay IG, Cook A, et al (2003) Complementary and alternative medicine use by patients with cancer in Wales: a cross sectional survey. Complement Ther Med 11(4):249-253
7. Hattori T, Ikematsu S, Koito A, et al (1989) Preliminary evidence for inhibitory effect of glycyrrhizin on HIV replication in patients with AIDS. Antiviral Res 11:255-261
8. Kanazawa M, Satomi Y, Mizutani Y, et al (2003) Isoliquiritigenin inhibits the growth of prostate cancer. Eur Urol 43:580-586
9. Lin SH, Chiu JS, Hsu CW, Chau T (2003) A simple and rapid approach to hypokalemic paralysis. Am J Emerg Med 21:487-491
10. Maggiolini M, Statti G, Vivacqua A, et al (2002) Estrogenic and antiproliferative activities of isoliquiritigenin in MCF7 breast cancer cells. J Steroid Biochem Mol Biol 82:315-22
11. Pan MH, Huang MC, Wang YJ, et al (2003) Induction of apoptosis by hydroxydibenzoylmethane through coordinative modulation of cyclin D3, Bcl-X(L), and Bax, release of cytochrome c, and sequential activation of caspases in human colorectal carcinoma cells. J Agric Food Chem 51:3977-3984
12. Small EJ, Frohlich MW, Bok R, et al (2000) Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer. J Clin Oncol 18:3595-3603
13. Stewart PM, Corrie JET, Shackleton CHL, et al (1988) Syndrome of apparent mineralocorticoid excess: a defect in the cortisol-cortisone shuttle. J Clin Invest 83:340-349
14. Stormer FC, Reistad R, Alexander J (1993) Glycyrrhizic acid in liquorice - evaluation of health hazard. Food Chem Toxicol 31:303-312
15. Wang ZY, Nixon DW (2001) Licorice and cancer. Nutr Cancer 39:1-11
16. Walker BR, Edwards CR (1994) Licorice-induced hypertension and syndromes of apparent mineralocorticoid excess. Endocrinol Metab Clin North Am 23:359-377
17. Wilkinson S, Chodak GW (2003) Critical review of complementary therapies for prostate cancer. J Clin Oncol 21:2199-2210